Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Figg

Showing results (71-80 of 638) with videos related to

Pageof 64
Sort By:
Cancer Biology & Therapy|September 5, 2008
Combining mTOR inhibition with metronomic chemotherapy in targeting angiogenesisCindy H Chau, Weixin Wang, William D Figg
Cancer Biology & Therapy|December 19, 2006
DNA microarrays: tissue removal and processing affects gene expressionSandra Ockers, Douglas K Price, William D Figg
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 18, 2008
Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detectionXiaohong Chen, Erin R Gardner, William D Figg
Current Neuropharmacology|July 11, 2008
Peripheral neuropathy induced by paclitaxel: recent insights and future perspectivesCharity D Scripture, William D Figg, Alex Sparreboom
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Treatment options for androgen-independent prostate cancerJames Gulley, William D Figg, William L Dahut
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 8, 2005
Pharmacogenetics of irinotecan metabolism and transport: an updateNicola F Smith, William D Figg, Alex Sparreboom
Cancer Biology & Therapy|July 10, 2014
Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivationAnjali Srivastava, Douglas K Price, William D Figg
Cancer Biology & Therapy|August 27, 2020
Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancerVincent Chau, Ravi A Madan, William D Figg
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 15, 2008
Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatmentErin R Gardner, William Dahut, William D Figg
Cancer Biology & Therapy|September 8, 2012
Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancerElias Pratt, Tristan M Sissung, William D Figg
Pageof 64

Showing results (71-80 of 638) with videos related to

Sort By:
Pageof 64
Cancer Biology & Therapy|September 5, 2008
Combining mTOR inhibition with metronomic chemotherapy in targeting angiogenesisCindy H Chau, Weixin Wang, William D Figg
Cancer Biology & Therapy|December 19, 2006
DNA microarrays: tissue removal and processing affects gene expressionSandra Ockers, Douglas K Price, William D Figg
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 18, 2008
Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detectionXiaohong Chen, Erin R Gardner, William D Figg
Current Neuropharmacology|July 11, 2008
Peripheral neuropathy induced by paclitaxel: recent insights and future perspectivesCharity D Scripture, William D Figg, Alex Sparreboom
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Treatment options for androgen-independent prostate cancerJames Gulley, William D Figg, William L Dahut
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 8, 2005
Pharmacogenetics of irinotecan metabolism and transport: an updateNicola F Smith, William D Figg, Alex Sparreboom
Cancer Biology & Therapy|July 10, 2014
Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivationAnjali Srivastava, Douglas K Price, William D Figg
Cancer Biology & Therapy|August 27, 2020
Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancerVincent Chau, Ravi A Madan, William D Figg
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 15, 2008
Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatmentErin R Gardner, William Dahut, William D Figg
Cancer Biology & Therapy|September 8, 2012
Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancerElias Pratt, Tristan M Sissung, William D Figg
Pageof 64